Literature DB >> 23382466

Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy.

Freek W A Verheugt1, Peter Clemmensen, Roxana Mehran, Stefan Agewall, Stuart J Pocock, Sidney Goldstein, Christian Torp-Pedersen, Maarten L Simoons, Jeffrey S Borer, Yasser M Khder, Paul Burton, Efthymios Deliargyris, John J V McMurray, Scott D Berkowitz, Wendy Gattis Stough, Faiez Zannad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23382466     DOI： 10.1093/eurheartj/eht013

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  3 in total

1.  Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes.

Authors:  Alexander C Fanaroff; Derek Cyr; Megan L Neely; Jeffery Bakal; Harvey D White; Keith A A Fox; Paul W Armstrong; Renato D Lopes; E Magnus Ohman; Matthew T Roe
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-12

Review 2.  Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysis.

Authors:  Alexander C Fanaroff; Vic Hasselblad; Matthew T Roe; Deepak L Bhatt; Stefan K James; Ph Gabriel Steg; C Michael Gibson; E Magnus Ohman
Journal:  Int J Cardiol       Date:  2017-03-14       Impact factor: 4.164

3.  Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints.

Authors:  Patrick Rossignol; Rajiv Agarwal; Bernard Canaud; Alan Charney; Gilles Chatellier; Jonathan C Craig; William C Cushman; Ronald T Gansevoort; Bengt Fellström; Dahlia Garza; Nicolas Guzman; Frank A Holtkamp; Gerard M London; Ziad A Massy; Alexandre Mebazaa; Peter G M Mol; Marc A Pfeffer; Yves Rosenberg; Luis M Ruilope; Jonathan Seltzer; Amil M Shah; Salim Shah; Bhupinder Singh; Bergur V Stefánsson; Norman Stockbridge; Wendy Gattis Stough; Kristian Thygesen; Michael Walsh; Christoph Wanner; David G Warnock; Christopher S Wilcox; Janet Wittes; Bertram Pitt; Aliza Thompson; Faiez Zannad
Journal:  Eur Heart J       Date:  2019-03-14       Impact factor: 29.983
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.